GET THE APP

Medical & Surgical Urology

Medical & Surgical Urology
Open Access

ISSN: 2168-9857

+44-20-4587-4809

Medical & Surgical Urology : Citations & Metrics Report

Articles published in Medical & Surgical Urology have been cited by esteemed scholars and scientists all around the world. Medical & Surgical Urology has got h-index 7, which means every article in Medical & Surgical Urology has got 7 average citations.

Following are the list of articles that have cited the articles published in Medical & Surgical Urology.

  2021 2020 2019 2018

Year wise published articles

55 24 11 19

Year wise citations received

26 26 14 24
Journal total citations count 199
Journal impact factor 0.58
Journal 5 years impact factor 0.79
Journal cite score 0.73
Journal h-index 7
Journal h-index since 2018 4
Important citations (253)

Rigo s, cai c, gunkel�grabole g, maurizi l, zhang x, xu j, et al. nanoscience�based strategies to engineer antimicrobial surfaces. advanced science. 2018;5(5):1700892.

Freisleben hj. the main (glyco) phospholipid (mpl) of thermoplasma acidophilum. international journal of molecular sciences. 2019;20(20):5217.

Bnouni n, mechi o, rekik i, rhim ms, amara ne. semi-automatic lymph node segmentation and classification using cervical cancer mr imaging. in2018 4th international conference on advanced technologies for signal and image processing (atsip). 2018; pp:1-6).

Hou g, zheng y, di wei xa, wang f, tian j, zhang g, et al. development and validation of a seer-based prognostic nomogram for patients with bone metastatic prostate cancer. medicine. 2019;98(39).

Hou g, zheng y, wei d, tian j, wang f, zhang g, et al. development and validation of the first multi-racial prognostic nomogram for patients with bone metastatic prostate cancer worldwide.

Narita s, nomura k, hatakeyama s, takahashi m, sakurai t, kawamura s, et al. changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy. cancer medicine. 2019.

Afriansyah a, hamid ar, mochtar ca, umbas r. survival analysis and development of a prognostic nomogram for bone�metastatic prostate cancer patients: a single�center experience in indonesia. international journal of urology. 2019;26(1):83-89.

Miyoshi y, ohtaka m, kawahara t, ohtake s, yasui m, uemura k, et al. prediction of time to castration-resistant prostate cancer using low-molecular-weight protein tyrosine phosphatase expression for men with metastatic hormone-naïve prostate cancer. urologia internationalis. 2019;102(1):37-42.

Miyoshi y, yoneyama s, kawahara t, hattori y, teranishi ji, ohta ji, et al. prediction of time to castration-resistant prostate cancer using bone scan index in men with metastatic hormone-sensitive prostate cancer. urologia internationalis. 2017;99(4):400-405.

Shiota m, namitome r, kobayashi t, inokuchi j, tatsugami k, et al. prognostic significance of risk stratification in chaarted and latitude studies among japanese men with de novo metastatic prostate cancer. international journal of urology. 2019;26(3):426-428.

Zhao j, sun g, liao b, zhang x, armstrong cm, yin x, et al. novel nomograms for castration�resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer. bju international. 2018;122(6):994-1002.

Ohtaka m, miyoshi y, kawahara t, ohtake s, yasui m, uemura k, et al. low-molecular-weight protein tyrosine phosphatase expression as a prognostic factor for men with metastatic hormone-naive prostate cancer. inurologic oncology: seminars and original investigations. elsevier. 2017;35(10):607-e9.

Miyoshi y, uemura k, kawahara t, yoneyama s, hattori y, teranishi ji, et al. prognostic value of automated bone scan index in men with metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate. clinical genitourinary cancer. 2017;15(4):472-478.

Wu j, lin g, zhu y, zhang h, shi g, shen y, et al. low tim3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status. scientific reports. 2017;7(1):8869.

Yu c, wang w. relationship between p15 gene mutation and formation and metastasis of malignant osteosarcoma. medical science monitor: international medical journal of experimental and clinical research. 2016;22:656.

Miyoshi y, yoneyama s, kawahara t, hattori y, teranishi ji, et al. prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases. bmc cancer. 2016;16(1):128.

Kuji i, yamane t, seto a, yasumizu y, shirotake s, oyama m. skeletal standardized uptake values obtained by quantitative spect/ct as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer. european journal of hybrid imaging. 2017;1(1):2. 

Uemura k, miyoshi y, kawahara t, yoneyama s, hattori y, teranishi ji,et al. prognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancer. bmc cancer. 2016;16(1):109.

Kawai k, sunami e, yamaguchi h, ishihara s, kazama s, nozawa h, et al. nomograms for colorectal cancer: a systematic review. world journal of gastroenterology. 2015;21(41):11877.

kamianowska m, szczepański m, wasilewska a. tubular and glomerular biomarkers of acute kidney injury in newborns. current drug metabolism. 2019.

Top